v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2024 $ 4 $ 403,024 $ (431,597) $ (28,569)
Balance at beginning (in shares) at Dec. 31, 2024 555,511      
Net Income (Loss)     2,453 2,453
Issuance of shares and reclassification of liability related to cashless warrant exercises $ 5 6,864   6,869
Issuance of shares and reclassification of liability related to cashless warrant exercises (in shares) 10,869,856      
Issuance of shares related to at-the-market offering, net   84   84
Issuance of shares related to at-the-market offering, net (in shares) 112,503      
Stock-based compensation expense   3,311   3,311
Balance at the ending at Jun. 30, 2025 $ 9 413,283 (429,144) (15,852)
Balance at ending (in shares) at Jun. 30, 2025 11,537,870      
Balance at the beginning at Mar. 31, 2025 $ 9 411,170 (422,502) (11,323)
Balance at beginning (in shares) at Mar. 31, 2025 10,538,615      
Net Income (Loss)     (6,642) (6,642)
Issuance of shares and reclassification of liability related to cashless warrant exercises   446   446
Issuance of shares and reclassification of liability related to cashless warrant exercises (in shares) 886,752      
Issuance of shares related to at-the-market offering, net   84   84
Issuance of shares related to at-the-market offering, net (in shares) 112,503      
Stock-based compensation expense   1,583   1,583
Balance at the ending at Jun. 30, 2025 $ 9 413,283 (429,144) (15,852)
Balance at ending (in shares) at Jun. 30, 2025 11,537,870      
Balance at the beginning at Dec. 31, 2025 $ 9 415,783 (470,819) $ (55,027)
Balance at beginning (in shares) at Dec. 31, 2025 12,105,902     12,105,902
Net Income (Loss)     (12,948) $ (12,948)
Issuance of pre-funded warrants related to PIPE financing   13,437   13,437
Issuance of shares related to at-the-market offering, net   2,551   2,551
Issuance of shares related to at-the-market offering, net (in shares) 2,282,929      
Issuance of shares related to exchange of convertible notes $ 1 31,488   31,489
Issuance of shares related to exchange of convertible notes (in shares) 11,918,380      
Modification of cash-settled restricted stock units   1,952   1,952
Stock-based compensation expense   3,185   3,185
Balance at the ending at Jun. 30, 2026 $ 10 468,396 (483,767) $ (15,361)
Balance at ending (in shares) at Jun. 30, 2026 26,307,211     26,307,211
Balance at the beginning at Mar. 31, 2026 $ 10 465,850 (482,612) $ (16,752)
Balance at beginning (in shares) at Mar. 31, 2026 25,303,058      
Net Income (Loss)     (1,155) (1,155)
Issuance of shares related to at-the-market offering, net   887   887
Issuance of shares related to at-the-market offering, net (in shares) 1,004,153      
Stock-based compensation expense   1,659   1,659
Balance at the ending at Jun. 30, 2026 $ 10 $ 468,396 $ (483,767) $ (15,361)
Balance at ending (in shares) at Jun. 30, 2026 26,307,211     26,307,211